and further support T-DXd as a valuable treatment option in this population,” they wrote in a scientific poster presented at the San Antonio Breast Cancer Symposium (SABCS) 2024. “We’re always worried ...
Medial EarlySign (earlysign.com), a pioneering company developing AI-based clinical predictive analytics, today announced a significant milestone with the publication of its 30th validated study in ...
Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific abstracts with clinical data from the SPARKLE Phase ...